Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

ACH-TERIFLUNOMIDE DIN 02502933

Status: Cancelled Post Market
Holder: ACCORD HEALTHCARE INC
Molecule: TERIFLUNOMIDE

Health Canada record

Active ingredient(s)TERIFLUNOMIDE 14 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCL04AK02 TERIFLUNOMIDE
Original market date19-May-2022
Current status date01-Nov-2024
SourceHealth Canada DPD

Establishment licence of the holder

Accord Healthcare Inc. — licence 101566, currently licensed, last inspection rating C (2024-11-26).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing TERIFLUNOMIDE

DINProductCompanyFormStrengthStatus
02500639APO-TERIFLUNOMIDEAPOTEX INCTabletTERIFLUNOMIDE 14 MGMarketed
02500515AURO-TERIFLUNOMIDEAURO PHARMA INCTabletTERIFLUNOMIDE 14 MGApproved
02504170JAMP TERIFLUNOMIDEJAMP PHARMA CORPORATIONTabletTERIFLUNOMIDE 14 MGMarketed
02523833M-TERIFLUNOMIDEMANTRA PHARMA INCTabletTERIFLUNOMIDE 14 MGMarketed
02500310NAT-TERIFLUNOMIDENATCO PHARMA (CANADA) INCTabletTERIFLUNOMIDE 14 MGMarketed
02500434PMS-TERIFLUNOMIDEPHARMASCIENCE INCTabletTERIFLUNOMIDE 14 MGMarketed
02505843SANDOZ TERIFLUNOMIDESANDOZ CANADA INCORPORATEDTabletTERIFLUNOMIDE 14 MGMarketed
02501090TEVA-TERIFLUNOMIDETEVA CANADA LIMITEDTabletTERIFLUNOMIDE 14 MGMarketed
02416328AUBAGIOSANOFI-AVENTIS CANADA INCTabletTERIFLUNOMIDE 14 MGCancelled Post Market
02500469MAR-TERIFLUNOMIDEMARCAN PHARMACEUTICALS INCTabletTERIFLUNOMIDE 14 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
281622022-05-16Abbreviated New Drug Submission (ANDS)
281712022-05-16Supplement to an Abbreviated New Drug Submission (SANDS)Update to product monograph per Advisement Letter

International API supply for TERIFLUNOMIDE

15 valid EDQM Certificates of Suitability from 14 holders. 21 active FDA Drug Master Files.

Request a quote for ACH-TERIFLUNOMIDE

How to read a Canadian DIN record